Media Coverage
September 29, 2020
2020
2020
Swift Biosciences and BillionToOne Partner Together for Commercialization and Manufacturing of EUA Approved COVID-19 Test
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remai
Share this post
Copy URL
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.
LinkedIn
X
News & Media
Press Releases
December 9, 2025
BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair
Read Article
Press Releases
December 9, 2025
BillionToOne Appoints Anthony Pagano to Board of Directors as Audit Committee Chair
Read Article
Press Releases
December 9, 2025
BillionToOne Reports Third Quarter 2025 Results
Read Article
Press Releases
December 9, 2025
BillionToOne Reports Third Quarter 2025 Results
Read Article
Press Releases
December 2, 2025
BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025
Read Article
Press Releases
December 2, 2025
BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025
Read Article
Press Releases
November 7, 2025
BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Read Article
Press Releases
November 7, 2025
BillionToOne Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Read Article
Media Coverage
November 6, 2025
Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test Demand
Read Article
Media Coverage
November 6, 2025
Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test Demand
Read Article
Media Coverage
November 6, 2025
BillionToOne IPO becomes $5 billion explosion as Bay Area medical test maker’s stock doubles in debut
Read Article
Media Coverage
November 6, 2025
BillionToOne IPO becomes $5 billion explosion as Bay Area medical test maker’s stock doubles in debut
Read Article
Media Coverage
November 6, 2025
BillionToOne valued at $4.4 billion as shares surge in blockbuster Nasdaq debut
Read Article
Media Coverage
November 6, 2025
BillionToOne valued at $4.4 billion as shares surge in blockbuster Nasdaq debut
Read Article
Media Coverage
November 6, 2025
BillionToOne Shares Surge Following Firm’s $273M IPO
Read Article
Media Coverage
November 6, 2025
BillionToOne Shares Surge Following Firm’s $273M IPO
Read Article
Media Coverage
November 6, 2025
How A Turkish Immigrant Engineered A Successful Diagnostics Startup IPO
Read Article
Media Coverage
November 6, 2025
How A Turkish Immigrant Engineered A Successful Diagnostics Startup IPO
Read Article
Media Coverage
November 6, 2025
Opening Bell: November 6, 2025
Read Article
Media Coverage
November 6, 2025
Opening Bell: November 6, 2025
Read Article